Premium
Are recombinant products really infection risk free?
Author(s) -
Minor P. D.
Publication year - 2001
Publication title -
haemophilia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.213
H-Index - 92
eISSN - 1365-2516
pISSN - 1351-8216
DOI - 10.1111/j.1365-2516.2001.00467.x
Subject(s) - medicine , recombinant dna , risk analysis (engineering) , product (mathematics) , microbiology and biotechnology , biology , biochemistry , gene , geometry , mathematics
Biological medicinal products can be manufactured from a variety of sources. Recombinant products are currently produced from extremely well characterised cells grown in vitro and priori pose the lowest risk of transmitting infection. Validated production processes make a major contribution to product safety however.